Your browser doesn't support javascript.
loading
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Zhang, Yuanyuan; Zhong, Yanyan; Pan, Lin; Dong, Jing.
Affiliation
  • Zhang Y; Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Zhong Y; Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Pan L; Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Dong J; Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Drug Discov Ther ; 14(2): 100-102, 2020.
Article in En | MEDLINE | ID: mdl-32378647
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Drug Discov Ther Year: 2020 Document type: Article Affiliation country: China Country of publication: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Drug Discov Ther Year: 2020 Document type: Article Affiliation country: China Country of publication: Japan